Vera Therapeutics Inc Cash Flow-to-Debt Ratio
Vera Therapeutics Inc cash flow-to-debt ratio. Vera Therapeutics Inc (VERA) has a Cash Flow-to-Debt Ratio of -0.87x as of March 2026, meaning its operating cash flow of $-106.50 Million could theoretically repay -1% of its total liabilities ($122.04 Million) in one year. See how financially flexible is Vera Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Vera Therapeutics Inc (2019–2025)
Cash flow-to-debt ratio of Vera Therapeutics Inc from 2019 to 2025. Historical debt coverage capacity for Vera Therapeutics Inc across 7 annual periods. Also explore Vera Therapeutics Inc net asset momentum to track the company's year-over-year net asset growth rate.
Vera Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2019–2025)
Vera Therapeutics Inc cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Vera Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Vera Therapeutics Inc generate cash.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.85x | $-241.10 Million | $130.21 Million | ▼ -8.0% |
| 2024 | -1.72x | $-134.68 Million | $78.53 Million | ▼ -37.4% |
| 2023 | -1.25x | $-92.18 Million | $73.86 Million | ▼ -0.7% |
| 2022 | -1.24x | $-67.60 Million | $54.53 Million | ▲ +26.0% |
| 2021 | -1.67x | $-23.71 Million | $14.16 Million | ▼ -592.4% |
| 2020 | -0.24x | $-34.81 Million | $143.90 Million | ▲ +1.4% |
| 2019 | -0.25x | $-10.29 Million | $41.93 Million | — |